J, H., W, X., M, W., Y, W., M, S., Y, Z., . . . S, L. (2021). MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis. Dove Medical Press.
Style de citation Chicago (17e éd.)J, Huang, Xue W, Wang M, Wu Y, Singh M, Zhu Y, Kumar R, et Lin S. MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis. Dove Medical Press, 2021.
Style de citation MLA (8e éd.)J, Huang, et al. MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis. Dove Medical Press, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.